Back
Solid Biosciences Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
42
SLDB
Solid Biosciences
Last Price:
$3.20
Seasonality Move:
14.73%
Sell
49
SRPT
Sarepta Therapeutics
Last Price:
$37.60
Seasonality Move:
5.56%
Sell
42
Solid Biosciences (SLDB)
is a Sell
Is Solid Biosciences a Buy, Sell or Hold?
-
The current Solid Biosciences [SLDB] share price is $3.21. The Score for SLDB is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
SLDB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $37.60. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SLDB Stock Price Chart
What is Solid Biosciences's stock price today?
-
The Solid Biosciences share price today is $3.21The current trend is relatively stagnant and SLDB is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $37.60Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.
SLDB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 52.03 | Buy |
Chaikin Money Flow: | 289649 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.65 - 3.53) | Buy |
Bollinger Bands (100): | (2.76 - 4.8) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.24 | Sell |
Relative Strength Index (14 RSI): | 33.32 | Sell |
Chaikin Money Flow: | 233958 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.61 - 55.83) | Sell |
Bollinger Bands (100): | (50.59 - 112.97) | Sell |
SLDB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.02 | Buy |
20-day SMA: | 3.03 | Buy |
50-day SMA: | 3.28 | Sell |
200-day SMA: | 5.09 | Sell |
8-day EMA: | 3.08 | Buy |
20-day EMA: | 3.05 | Buy |
50-day EMA: | 3.35 | Sell |
200-day EMA: | 4.77 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.57 | Sell |
20-day SMA: | 40.5 | Sell |
50-day SMA: | 52.86 | Sell |
200-day SMA: | 103.8 | Sell |
8-day EMA: | 38.28 | Sell |
20-day EMA: | 41.88 | Sell |
50-day EMA: | 55.25 | Sell |
200-day EMA: | 92.54 | Sell |
Solid Biosciences Earnings Growth & SLDB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.75 per share, and an increase next year of $0.01 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.74 per share, an increase next quarter of $0.95 per share, a decrease this year of $3.92 per share, and an increase next year of $7.74 per share.
Solid Biosciences Technical Analysis
May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |